The resolvin D2 – GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice

This publication has 28 references indexed in Scilit:

• Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
• Annexin A1 Counteracts Chemokine-Induced Arterial Myeloid Cell Recruitment
  Circulation Research, 2015
• Anti-inflammatory therapies for atherosclerosis
  Nature Reviews Cardiology, 2015
• The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
  Cardiovascular Research, 2014
• Δ⁹‐Tetrahydrocannabinol andN‐arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC‐1B cells
  British Journal of Pharmacology, 2011
• Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe ^−/− Mice
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
• The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
  British Journal of Pharmacology, 2007
• Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability
  Cardiovascular Research, 2007
• Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages
  Journal of Biological Chemistry, 2002
• Resolvins
  Journal of Experimental Medicine, 2002